Correction to “Prevention and treatment of venous thromboembolism in patients with multiple myeloma: Clinical practice guidelines on behalf of the European Myeloma Network”

Documenti analoghi

• Sequencing BCMA‐ and GPRC5D‐targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network
  di: Niels W. C. J. van de Donk, et al.
  Pubblicazione: (2025)
• European Myeloma Network Group Consensus Statement on the use of next‐generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
  di: Niccolò Bolli, et al.
  Pubblicazione: (2025)
• New horizons in the pharmacological management of venous thromboembolism
  di: Andreas Verstraete, et al.
  Pubblicazione: (2025)
• Extended treatment for venous thromboembolism: Is direct oral anticoagulant dose‐reduction better for all?
  di: Mandy N. Lauw, et al.
  Pubblicazione: (2026)
• Evaluation of the R2‐ISS in real‐world patients with newly diagnosed multiple myeloma: A nationwide cohort study by the Korean Multiple Myeloma Working Party (KMM 2202)
  di: Hyungwoo Cho, et al.
  Pubblicazione: (2024)